Back

Simianalytica

Ghost
simianalytica.com· irregular· Inactive for over a year

Simianalytica covers diabetes device technology, offering regulatory analysis of new glucose monitoring products such as Biolinq's FDA De Novo classification and commentary on noninvasive glucose efforts. Readers get concise explanations of regulatory details, product code assignments and industry developments, though the sampled issues are short and partly link-based.

continuous glucose monitorbiolinqfda de novononinvasive glucosediabetes devicesmedical device regulationglucose range monitordiabetes technology newsfda product codewearable health
Platform
Ghost
Frequency
Irregular
Latest issue
Oct 1, 2025
Language
English
Written for
Diabetes device professionals, investors and health technology analysts
Tone
analytical
Tracked since
Oct 22, 2026

Website: https://www.simianalytica.com/